•  
  •  
 

Abstract

The article reports on the benefits of federal preemption on the regulation of prescription drug warning labels by the U.S. Food and Drug Administration (FDA). The Wyeth vs. Levine case is presented which highlights the significance of a common direction between federal and state government. The presumption against federal preemption that guided the Court's decision is discussed. The possible consequences from denying federal preemption for prescription drugs are discussed.

Share

COinS
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.